The role of immunotherapy in treatment of patients with community-acquired pneumonia
Saved in:
| Date: | 2014 |
|---|---|
| Main Authors: | Ju. Khimich, O. S. Bilchenko, E. V. Avdeeva, V. A. Klapoukh, V. V. Sirota |
| Format: | Article |
| Language: | English |
| Published: |
2014
|
| Series: | International medical journal |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000137052 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
The role of cytokine in differential diagnosis and treatment optimization at community acquired pneumonia in patients with diabetes mellitus
by: O. S. Makharynska, et al.
Published: (2015)
by: O. S. Makharynska, et al.
Published: (2015)
Dynamics of changes of inflammation indicators in patients with community-acquired pneumonia and concomitant chronic heart failure
by: I. H. Berezniakov, et al.
Published: (2017)
by: I. H. Berezniakov, et al.
Published: (2017)
The optimal choice of antibacterial therapy in the treatment of community-acquired pneumonia in the practice of family physician and therapist
by: I. V. Andrusyshyna, et al.
Published: (2020)
by: I. V. Andrusyshyna, et al.
Published: (2020)
"Clarithromycin-MB" clinical efficacy in combined therapy of patients with community-acquired pneumonia
by: T. I. Liadova, et al.
Published: (2020)
by: T. I. Liadova, et al.
Published: (2020)
The content of procalcitonin and galectin-3 in the blood of patients with community-acquired pneumonia and concomitant chronic heart failure and without it
by: V. I. Bereznjakov, et al.
Published: (2015)
by: V. I. Bereznjakov, et al.
Published: (2015)
Community-acquired uncomplicated pneumonia of children: interaction with cytokin response and physical development
by: O. S. Borodina
Published: (2018)
by: O. S. Borodina
Published: (2018)
Combination of chemotherapy and immunotherapy in cancer patients treatment (review)
by: N. E. Prokhach, et al.
Published: (2017)
by: N. E. Prokhach, et al.
Published: (2017)
Pneumonia lethal outcome predictors in patients with oncohematological diseases
by: I. S. Borysova, et al.
Published: (2017)
by: I. S. Borysova, et al.
Published: (2017)
Efficacy of different immunotherapy approaches toward treatment of doxorubicin-resistant and doxorubicinsensitive transplantable rhabdomyosarcoma
by: Belova, O.B., et al.
Published: (2007)
by: Belova, O.B., et al.
Published: (2007)
Accompanying immunotherapy using cord blood cryopreserved hemopoietic cells to treat patients with subacute salpingo-oophoritis
by: V. I. Grishchenko, et al.
Published: (2004)
by: V. I. Grishchenko, et al.
Published: (2004)
Antibiotic resistance of the microflora, isolated from sputum of patients with pneumonia and chronic bronchitis
by: S. V. Kozulja, et al.
Published: (2014)
by: S. V. Kozulja, et al.
Published: (2014)
Macrophages — a perspective target for antineoplastic immunotherapy
by: Karaman, О.М., et al.
Published: (2023)
by: Karaman, О.М., et al.
Published: (2023)
Immunotherapy of Diseases and Nanotechnology: Current State and Prospects
by: O. F. Piminov, et al.
Published: (2024)
by: O. F. Piminov, et al.
Published: (2024)
Comparative assessment immunity changes in patients with chronic acquired toxoplasmosis at different types of therapy
by: E. I. Bodnja, et al.
Published: (2017)
by: E. I. Bodnja, et al.
Published: (2017)
Membrane vesicles formation technology for anticancer immunotherapy
by: R. O. Bilyi
Published: (2011)
by: R. O. Bilyi
Published: (2011)
Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy
by: Bereznaya, N.M., et al.
Published: (2007)
by: Bereznaya, N.M., et al.
Published: (2007)
Individualization of antibiotic therapy for pneumonia in patients with hemoblastosis from the perspective of antibiotic resistance
by: I. S. Borysova, et al.
Published: (2018)
by: I. S. Borysova, et al.
Published: (2018)
Clinical analysis of fatal outcome due to influenza A (H1N1)pdm complicated by pneumonia caused by Klebsiella pneumoniae in the post-pandemic period during extracorporeal membrane oxygenation
by: G. I. Gradil, et al.
Published: (2015)
by: G. I. Gradil, et al.
Published: (2015)
Features of pulmo-renal syndrome in patients with non-hospital pneumonia of a non-severe course
by: A. I. Hozhenko, et al.
Published: (2019)
by: A. I. Hozhenko, et al.
Published: (2019)
Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer
by: A. A. Kovalev, et al.
Published: (2013)
by: A. A. Kovalev, et al.
Published: (2013)
Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer
by: Kovalev, A.A., et al.
Published: (2013)
by: Kovalev, A.A., et al.
Published: (2013)
Role phagocytic activity of leukocytes in the blood pathogenesis formation for experimental pneumonia later period
by: S. M. Reheda, et al.
Published: (2016)
by: S. M. Reheda, et al.
Published: (2016)
The role of endothelioprotection in treatment of traumatic disease in patients with elevated body mass index
by: V. V. Kucherjavchenko
Published: (2018)
by: V. V. Kucherjavchenko
Published: (2018)
State of protein metabolism in the dynamics of experimental pneumonia
by: V. R. Yurevych, et al.
Published: (2015)
by: V. R. Yurevych, et al.
Published: (2015)
Using the combined chemo-immunotherapy based on dendritic cells and low-dose doxorubicin in experiment
by: O. I. Horbach, et al.
Published: (2013)
by: O. I. Horbach, et al.
Published: (2013)
Phagocytic activity of leukocytes in the dynamic of experimental pneumonia
by: O. O. Chuhai, et al.
Published: (2017)
by: O. O. Chuhai, et al.
Published: (2017)
Modeling the influence of diffusion perturbations on the development of infectious diseases taking the convection and immunotherapy into account
by: S. V. Baranovskyi, et al.
Published: (2021)
by: S. V. Baranovskyi, et al.
Published: (2021)
Information technology for the early diagnosys of pneumonia using convolutional neural networks
by: P. M. Radjuk, et al.
Published: (2021)
by: P. M. Radjuk, et al.
Published: (2021)
Treatment of patients with kidney cancer metastases to the lungs
by: A. G. Kudrjashov, et al.
Published: (2012)
by: A. G. Kudrjashov, et al.
Published: (2012)
Acquired distinctiveness for trademarks that are registering for the first time in Ukraine
by: O. A. Rassomakhina
Published: (2016)
by: O. A. Rassomakhina
Published: (2016)
Protection of T-lymphocytes via PD-1 receptor: New molecular mechanism of cancer immunotherapy
by: S. Szabo
Published: (2019)
by: S. Szabo
Published: (2019)
Ukrainian democracy: acquired features as lost opportunities
by: S. Kononenko
Published: (2012)
by: S. Kononenko
Published: (2012)
Remote Transfer System for Acquired Geophysical Data
by: L. H. Savkiv
Published: (2016)
by: L. H. Savkiv
Published: (2016)
The problem of adherence to long-term treatment of patients with cardiovascular diseases
by: E. A. Naumova, et al.
Published: (2014)
by: E. A. Naumova, et al.
Published: (2014)
Immunohistochemical features of spleen in pneumonia arisen on the background chronic heart failure
by: E. A. Pavlova
Published: (2015)
by: E. A. Pavlova
Published: (2015)
Application of Erbisol® Ultrapharm for the treatment of patients with pancreatic cancer
by: G. I. Maksimjak, et al.
Published: (2019)
by: G. I. Maksimjak, et al.
Published: (2019)
Value of factors of nonspecific immunity for early period of experimental pneumonia
by: M. M. Reheda-Furdychko, et al.
Published: (2016)
by: M. M. Reheda-Furdychko, et al.
Published: (2016)
Software module for estimating subpixel shift of images acquired from quadcopter
by: S. A. Stankevich, et al.
Published: (2018)
by: S. A. Stankevich, et al.
Published: (2018)
Modeling of the COVID-19 pandemic in the limit of no acquired immunity
by: J. M. Ilnytskyi
Published: (2021)
by: J. M. Ilnytskyi
Published: (2021)
Approaches to combined treatment of patients with cardiopulmonary pathology
by: H. A. Tymchenko, et al.
Published: (2020)
by: H. A. Tymchenko, et al.
Published: (2020)
Similar Items
-
The role of cytokine in differential diagnosis and treatment optimization at community acquired pneumonia in patients with diabetes mellitus
by: O. S. Makharynska, et al.
Published: (2015) -
Dynamics of changes of inflammation indicators in patients with community-acquired pneumonia and concomitant chronic heart failure
by: I. H. Berezniakov, et al.
Published: (2017) -
The optimal choice of antibacterial therapy in the treatment of community-acquired pneumonia in the practice of family physician and therapist
by: I. V. Andrusyshyna, et al.
Published: (2020) -
"Clarithromycin-MB" clinical efficacy in combined therapy of patients with community-acquired pneumonia
by: T. I. Liadova, et al.
Published: (2020) -
The content of procalcitonin and galectin-3 in the blood of patients with community-acquired pneumonia and concomitant chronic heart failure and without it
by: V. I. Bereznjakov, et al.
Published: (2015)